ID: h-0f37721539
Hypothesis

BBB leak induces secondary pericyte senescence through TGF-beta-dominant stress signaling

Initial BBB disruption from another cause exposes the neurovascular unit to albumin, fibrinogen, and related plasma signals that activate TGF-beta/SMAD stress pathways and drive pericyte senescence secondarily.
🧬 TGFB1, TGFBR2, SMAD2, SMAD3🩺 neurodegeneration🎯 Composite 56%💱 $0.54▼4.4%proposed
EvidencePending (0%)📖 6 cit🗣 1 debates 6 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.62 (15%) Evidence 0.42 (15%) Novelty 0.69 (12%) Feasibility 0.71 (12%) Impact 0.49 (12%) Druggability 0.64 (10%) Safety 0.43 (8%) Competition 0.67 (6%) Data Avail. 0.46 (5%) Reproducible 0.45 (5%) KG Connect 0.50 (8%) 0.560 composite

🧪 Overview

Initial BBB disruption from another cause exposes the neurovascular unit to albumin, fibrinogen, and related plasma signals that activate TGF-beta/SMAD stress pathways and drive pericyte senescence secondarily. This creates a feed-forward loop in which senescence is initially downstream but later helps lock in chronic BBB dysfunction.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Astrocyte-Derived TGF-beta1<br/>Anti-inflammatory Ligand Source"]
    B["TGFBR2/TGFBR1 Complex Formation<br/>Microglial Receptor Activation"]
    C["SMAD2/3 Phosphorylation<br/>SMAD4 Corepressor Assembly"]
    D["RelA/p300 Displacement<br/>NF-kB Enhancer Rewiring"]
    E["TNF/IL1B/IL6 Suppression<br/>Trained Immunity Memory Reset"]
    F["Homeostatic Microglial State<br/>Inflammatory Tone Resolution"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style F fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix6 supports2 contradicts
Supports
BBB dysfunction can induce astrocyte senescence through albumin-triggered TGF-beta signaling, making an analogous neurovascular stress mechanism plausible.
Supports
Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis.
Brain2025PMID:39718981medium
Supports
Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS.
Cells2023PMID:37048104medium
Supports
Complex Inflammation mRNA-Related Response in ALS Is Region Dependent.
Neural Plast2015PMID:26301107medium
Supports
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.
Ann Neurol2015PMID:25381879medium
Supports
Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients.
Neurobiol Aging2019PMID:31394426medium
Contradicts
The supporting evidence is in astrocytes rather than pericytes, so the core mechanism is an extrapolation across cell types.
Contradicts
Pericyte changes after leak may be indirect and mediated through astrocytes or microglia rather than direct TGF-beta stress in pericytes.
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — TGFB1

No curated PDB or AlphaFold mapping for TGFB1 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for TGFB1, TGFBR2, SMAD2, SMAD3 from GTEx v10.

Spinal cord cervical c-118.2 Substantia nigra14.3 Hypothalamus12.4 Amygdala9.7 Cortex9.2 Caudate basal ganglia9.1 Nucleus accumbens basal ganglia8.6 Hippocampus8.1 Putamen basal ganglia8.0 Anterior cingulate cortex BA247.8 Frontal Cortex BA96.4 Cerebellum6.1 Cerebellar Hemisphere4.0median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TGFB1, TGFBR2, SMAD2, SMAD3 →

No DepMap CRISPR Chronos data found for TGFB1, TGFBR2, SMAD2, SMAD3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.2%
Volatility
Low
0.0053
Events (7d)
2
Price History
▼4.4%

💾 Resource Usage

LLM Tokens
17,540
$0.0526
Total Cost
$0.0526

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF adult C57BL/6J mice with controlled cortical impact (CCI) brain injury receive oral TGFBR2 kinase inhibitor (SM16 at 10 mg/kg twice daily) starting 1 hour post-injury for 7 days, THEN we will obserPericyte senescence markers (p21, SA-β-gal) will be reduced by ≥40% in TGF-beta-inhibited mice compared to vehicle controls at 7 days post-CCI, while BBB leakag— no observation —pending0.72
IF we prospectively measure plasma TGFB1 (ELISA) and pericyte-derived exosomal markers (exosomal CD13, exosomal PDGFRB) in acute ischemic stroke patients (n=80, NIHSS 5-20) within 6 hours of onset andPatients with highest tertile TGFB1 increase will show ≥2-fold higher exosomal senescence markers compared to lowest tertile, and this relationship will remain — no observation —pending0.68
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF adult C57BL/6J mice with controlled cortical impact (CCI) brain injury receive oral TGFBR2 kinase inhibitor (SM16 at 10 mg/kg twice daily) starting 1 hour post-injury for 7 days, THEN we will observe a statistically significant reduction in pericyte senescence markers (p21+ cells per capillary, S
Predicted outcome: Pericyte senescence markers (p21, SA-β-gal) will be reduced by ≥40% in TGF-beta-inhibited mice compared to vehicle controls at 7 days post-CCI, while
Falsification: No significant difference in pericyte senescence markers between TGF-beta inhibitor and vehicle groups (p > 0.05, Mann-Whitney U test), OR reduction in senescence occurs without BBB disruption (sugges
pendingconf 68%
IF we prospectively measure plasma TGFB1 (ELISA) and pericyte-derived exosomal markers (exosomal CD13, exosomal PDGFRB) in acute ischemic stroke patients (n=80, NIHSS 5-20) within 6 hours of onset and again at 72 hours, THEN we will observe a significant positive correlation (Spearman r > 0.45, p <
Predicted outcome: Patients with highest tertile TGFB1 increase will show ≥2-fold higher exosomal senescence markers compared to lowest tertile, and this relationship wi
Falsification: No significant correlation between plasma TGFB1 dynamics and pericyte exosomal markers (Spearman r < 0.25, p > 0.05), OR pericyte exosomal markers peak before TGFB1 elevation (temporal sequence opposi
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.